Fulgent Genetics’s Investor Alert: Kaplan Fox Reminds Investors of an Important Deadline
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and that November 21, 2022 is the deadline for seeking appointment as lead plaintiff.
- NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and that November 21, 2022 is the deadline for seeking appointment as lead plaintiff.
- WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.
- With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.
- Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.